Luxury Buyer Interest Doubles Across U.S. Luxury Homes
In the first five months of 2026, luxury buyer interest doubles in the U.S. luxury market, with buyers favoring large...
Using points for maximum value experiences can elevate your lifestyle. Learn how to leverage your rewards for unforgettable moments.
23,434 articlesIn the first five months of 2026, luxury buyer interest doubles in the U.S. luxury market, with buyers favoring large...
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
In late 2025, Berkshire added 8 million shares to a major energy producer, lifting its portfolio weight. This move po...
As the first federal reserve inflation forecast for March lands, markets wrestle with what it signals for rate paths ...
A single, sizable move out of a momentum ETF can reveal where market leadership is shifting. This article explains wh...
Two automotive giants draw the attention of investors with shifting revenue engines. This deep dive breaks down Ford ...
As AI stocks drive gains, traders debate whether equal-weighted ETFs like RSP can outpace SPY’s cap-weighted edge. He...
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Abbott Laboratories moved higher after boosting its profit outlook and signaling strength across its diagnostics and ...
A sharp upgrade, new AI partnerships, and a strategic move to Miami illuminate Palantir's potential. Learn how these ...
As Magnachip heads into 2025 earnings season, investors want clarity on revenue growth, margins, and capital allocati...
Looking for long-term oil exposure you can ride through cycles? Discover why ExxonMobil and Chevron are strong candid...